📊 Score Breakdown
Offering Ability
100
Cash Runway
85
Float Risk
10
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
60%
💰 Capital Raise
73%
• Low cash runway: 4 months remaining
• Active shelf registration ($100M, 206% of market cap)
📉 Score Deterioration
50%
• Score rose 52 points recently (worsening)
• Score in HIGH risk zone (71/100)
🔄 Reverse Split
45%
• 50-day avg $1.00 approaching $1 threshold
• Only 4 months cash — financial pressure
💹 Market Data
Market Cap$48.57M
Shares Outstanding55.51M
Float47.17M
Cash$2.04M
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 35.7% shares (2025Q4 vs prior)
41 institutional holders · 4.56M shares
#1
VANGUARD GROUP INC
1.08M shares
#2
BlackRock, Inc.
892.2K shares
#3
UBS Group AG
453.7K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest2.59M
Days to Cover3.0
% of Float5.5%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Sep 30, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2023
4
INSIDER TRANSACTION
Apr 16, 2026
4
INSIDER TRANSACTION
Apr 16, 2026
4
INSIDER TRANSACTION
Apr 16, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for BEAT
📊 BEAT FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 BEAT Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.